Hiramanek Navaz, Kossard Steven, Barnetson Ross StC
Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.
Australas J Dermatol. 2002 May;43(2):136-9. doi: 10.1046/j.1440-0960.2002.00577.x.
A case of multicentric reticulohistiocytosis in a 53-year-old woman with a history of generalized cutaneous eruptions followed by arthralgia is presented. A thorough malignancy screen was performed with negative results. Treatment was commenced with oral prednisone 20 mg daily, which rapidly resulted in marked improvement of joint symptoms and resolution of self-perceived functional disability. As there was little improvement of her rash, oral azathioprine was added at 100 mg daily. Both drugs were well-tolerated and the patient was discharged from hospital on these medications. Two months later the azathioprine was reduced to 50 mg per day orally, following a small rise in hepatic transaminases. Within 4 months there had been dramatic improvement in the rash and cutaneous nodules with complete remission of the arthralgia and pruritus. During this time the oral prednisone had gradually been decreased to 10 mg daily. To date only the periungual nodules persist.
报告了一例53岁女性的多中心网状组织细胞增多症,该患者有全身性皮肤疹病史,随后出现关节痛。进行了全面的恶性肿瘤筛查,结果为阴性。开始每天口服20毫克泼尼松进行治疗,这迅速使关节症状得到显著改善,并消除了自我感觉的功能障碍。由于她的皮疹改善甚微,于是每天加用100毫克硫唑嘌呤口服。两种药物耐受性良好,患者出院时继续服用这些药物。两个月后,由于肝转氨酶略有升高,硫唑嘌呤减至每天口服50毫克。4个月内,皮疹和皮肤结节有显著改善,关节痛和瘙痒完全缓解。在此期间,口服泼尼松已逐渐减至每天10毫克。迄今为止,仅甲周结节仍然存在。